glp-1 news november 2025 today fda warning The FDA has approved the first GLP-1 pill We have some bad news:

This is a normal and purely cosmetic effect

Nrf2 activation regulates antioxidant responses to modify cellular redox states from predominantly pro-oxidant to antioxidant, and, in an antioxidant environment, macrophage phenotypes shift from M1 pro-inflammatory to M2 anti-inflammatory, reducing the probability of cytokine storms, ARDS, and lethality (Tan et al., 2016

Note that neither plan is available to people on Medicare, Medicaid, or other government-funded plans

Alcohol can worsen the GI side effects of tirzepatide (nausea, vomiting, abdominal pain) and may interfere with metabolic processes that levocarnitine is intended to support